Investors 1
| Date | Name | Website |
| 01.02.2026 | Berkeley F... | berkeleyfr... |
Mentions in press and media 3
| Date | Title | Description |
| 16.01.2026 | Vivere Oncotherapies Secures $10M+ to Revolutionize Cold Tumor Treatment | Vivere Oncotherapies raised over $10 million. This significant funding fuels their innovative platform. The Berkeley biotech targets "cold" solid tumors. These cancers historically evade immune detection. They resist conventional ... |
| 14.01.2026 | Vivere Oncotherapies Raises Over $10M in Funding | Vivere Oncotherapies, a Berkeley, CA-based company developing cancer therapies that activate the immune system, raised over $10M in funding. Backers included YK Bioventures, Pillar, Berkeley Frontier Fund, Freeflow Ventures and The National... |
| - | Vivere Oncotherapies | “Vivere is developing next-generation cancer therapies aimed at activating the immune system to selectively detect and destroy cancer cells in cold tumors.” |